secwatch.observer — SEC 8-K summary
======================================

Issuer:     Transcode Therapeutics, Inc. (RNAZ)
CIK:        0001829635
Form:       8-K
Filed at:   2026-06-01T12:59:50+00:00
Accession:  0001104659-26-068647
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

TransCode Therapeutics sets July 2, 2026 annual meeting; proposal deadline June 11
--------------------------------------------------------------------------------

- Annual meeting scheduled for July 2, 2026; record date May 28, 2026.
- Stockholder proposals for proxy inclusion due by June 11, 2026 (5:00 p.m. ET).
- Director nominations and other business notices also due by June 11, 2026.
- Meeting date moved more than 30 days from 2025 annual meeting (Aug 29, 2025).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829635/000110465926068647/0001104659-26-068647-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829635/000110465926068647/tm2616319d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-068647

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer